Kalbhenn J - Search Results

1

Bleeding During Veno-Venous ECMO: Prevention and Treatment.

Kalbhenn J, Zieger B. Kalbhenn J, et al. Front Med (Lausanne). 2022 May 23;9:879579. doi: 10.3389/fmed.2022.879579. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35677828 Free PMC article. Review.

2

Early diagnosis of acquired von Willebrand Syndrome (AVWS) is elementary for clinical practice in patients treated with ECMO therapy.

Kalbhenn J, Schmidt R, Nakamura L, Schelling J, Rosenfelder S, Zieger B. Kalbhenn J, et al. J Atheroscler Thromb. 2015;22(3):265-71. doi: 10.5551/jat.27268. Epub 2014 Sep 4. J Atheroscler Thromb. 2015. PMID: 25186021 Free article.

3

Identification of acquired coagulation disorders and effects of target-controlled coagulation factor substitution on the incidence and severity of spontaneous intracranial bleeding during veno-venous ECMO therapy.

Kalbhenn J, Wittau N, Schmutz A, Zieger B, Schmidt R. Kalbhenn J, et al. Perfusion. 2015 Nov;30(8):675-82. doi: 10.1177/0267659115579714. Epub 2015 Mar 30. Perfusion. 2015. PMID: 25823366

4

Venovenous Extracorporeal Membrane Oxygenation With Prophylactic Subcutaneous Anticoagulation Only: An Observational Study in More Than 60 Patients.

Krueger K, Schmutz A, Zieger B, Kalbhenn J. Krueger K, et al. Among authors: kalbhenn j. Artif Organs. 2017 Feb;41(2):186-192. doi: 10.1111/aor.12737. Epub 2016 Jun 3. Artif Organs. 2017. PMID: 27256966

5

Is Extracorporeal CO2 Removal Really "Safe" and "Less" Invasive? Observation of Blood Injury and Coagulation Impairment during ECCO2R.

Kalbhenn J, Neuffer N, Zieger B, Schmutz A. Kalbhenn J, et al. ASAIO J. 2017 Sep/Oct;63(5):666-671. doi: 10.1097/MAT.0000000000000544. ASAIO J. 2017. PMID: 28187047

6

Bleeding during veno-venous ECMO cannot reliably be predicted by rotational thrombelastometry (ROTEM™).

Hellmann C, Schmutz A, Kalbhenn J. Hellmann C, et al. Among authors: kalbhenn j. Perfusion. 2018 May;33(4):289-296. doi: 10.1177/0267659117746231. Epub 2017 Nov 30. Perfusion. 2018. PMID: 29188749

7

Acquired von Willebrand syndrome and impaired platelet function during venovenous extracorporeal membrane oxygenation: Rapid onset and fast recovery.

Kalbhenn J, Schlagenhauf A, Rosenfelder S, Schmutz A, Zieger B. Kalbhenn J, et al. J Heart Lung Transplant. 2018 Aug;37(8):985-991. doi: 10.1016/j.healun.2018.03.013. Epub 2018 Mar 17. J Heart Lung Transplant. 2018. PMID: 29650295

8

Acquired von Willebrand Syndrome and Platelet Function Defects during Extracorporeal Life Support (Mechanical Circulatory Support).

Schlagenhauf A, Kalbhenn J, Geisen U, Beyersdorf F, Zieger B. Schlagenhauf A, et al. Among authors: kalbhenn j. Hamostaseologie. 2020 Jun;40(2):221-225. doi: 10.1055/a-1150-2016. Epub 2020 May 26. Hamostaseologie. 2020. PMID: 32455462 Review.

9

Acquired von Willebrand syndrome in ECMO patients: A 3-year cohort study.

Panholzer B, Bajorat T, Haneya A, Kowalski D, Juhl D, Rocke A, Shneyder M, Kuta P, Clausnizer H, Junker R, Kowalski A, Tulun A, Al-Suraimi A, Cremer J, Kalbhenn J, Zieger B, Nowak-Göttl U. Panholzer B, et al. Among authors: kalbhenn j. Blood Cells Mol Dis. 2021 Mar;87:102526. doi: 10.1016/j.bcmd.2020.102526. Epub 2020 Dec 10. Blood Cells Mol Dis. 2021. PMID: 33338698

10

Hypercoagulopathy, acquired coagulation disorders and anticoagulation before, during and after extracorporeal membrane oxygenation in COVID-19: a case series.

Kalbhenn J, Glonnegger H, Wilke M, Bansbach J, Zieger B. Kalbhenn J, et al. Perfusion. 2021 Sep;36(6):592-602. doi: 10.1177/02676591211001791. Epub 2021 Mar 15. Perfusion. 2021. PMID: 33719738

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

73 results

Search Page